These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21041907)

  • 1. Conclusion to 'Hepatitis B virus heterogeneity--a means to personalized care'.
    Bonino F;
    Antivir Ther; 2010; 15 Suppl 3():79-80. PubMed ID: 21041907
    [No Abstract]   [Full Text] [Related]  

  • 2. [Focusing on the markers for monitoring and antiviral therapy in chronic hepatitis B virus infection].
    Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):836-7. PubMed ID: 17125613
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction to 'Hepatitis B virus heterogeneity--a means to personalized care'.
    Bonino F;
    Antivir Ther; 2010; 15 Suppl 3():1-2. PubMed ID: 21041898
    [No Abstract]   [Full Text] [Related]  

  • 4. [HBV mutations during antiviral therapy in patients with chronic hepatitis B].
    Hwang SG
    Korean J Hepatol; 2005 Dec; 11(4):311-9. PubMed ID: 16380660
    [No Abstract]   [Full Text] [Related]  

  • 5. Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B.
    Yokosuka O
    J Gastroenterol; 2004 Aug; 39(8):813-4. PubMed ID: 15338383
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B therapy: the plot thickens.
    Malik AH; Lee WM
    Hepatology; 1999 Aug; 30(2):579-81. PubMed ID: 10421673
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential combination therapy for chronic hepatitis B: more challenges to be tackled.
    Tseng TC; Liu CJ; Kao JH
    Am J Gastroenterol; 2007 Jul; 102(7):1544; author reply 1545. PubMed ID: 17593169
    [No Abstract]   [Full Text] [Related]  

  • 8. [The influence of HBV genotypes on the therapeutic effects of lamivudine in chronic hepatitis B patients].
    Tan WT; Deng GH; Wang YM; Dan YJ; Kuang XM
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):540-1. PubMed ID: 18647538
    [No Abstract]   [Full Text] [Related]  

  • 9. [The genetic variability and clinical significance of hepatitis B virus].
    Tang H; Chen EQ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):161-3. PubMed ID: 19554777
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral therapy of chronic hepatitis B.
    Zoulim F
    Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HBeAg-negative chronic hepatitis].
    Ibragimova MM; Krel' PE; Abdurakhmanov DT
    Ter Arkh; 2004; 76(2):87-91. PubMed ID: 15106425
    [No Abstract]   [Full Text] [Related]  

  • 12. [YVDD is the primary symbol of gene mutation in hepatitis B patients treated with lamivudine].
    Tian Y; Du SC; Zhang R; Wei L; Chen Y; Han JD
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):455-6. PubMed ID: 15975283
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
    Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of lamivudine and interferon-alpha combination therapy on chronic hepatitis B].
    Tang Y; Chen G; Zheng R
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):89. PubMed ID: 11983118
    [No Abstract]   [Full Text] [Related]  

  • 15. High dose lamivudine and hepatitis B.
    Musher DR; Wasser WG; Saggi SJ
    Am J Gastroenterol; 1999 Nov; 94(11):3372. PubMed ID: 10566751
    [No Abstract]   [Full Text] [Related]  

  • 16. [Detection of YMDD motif mutations in lamivudine-untreated patients with chronic hepatitis B].
    Yan MH; Zhang C; Ling Q; Zhou RF
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):430-1. PubMed ID: 12890351
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiviral treatment of special patients groups with hepatitis B virus infection].
    Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):481-2. PubMed ID: 20678432
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of interferon combined with lamivudine in treatment of chronic hepatitis B patients infected with HBV with mutation of YMDD].
    Wu GX; Zha YS; Zheng J; Wang YZ; Zhou GP
    Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):752-3. PubMed ID: 14697141
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic hepatitis B and viral genotype: the clinical significance of determining HBV genotypes.
    Guettouche T; Hnatyszyn HJ
    Antivir Ther; 2005; 10(5):593-604. PubMed ID: 16152753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to overcome antiviral-resistant hepatitis B virus?
    Song BC
    Intervirology; 2010; 53(1):29-38. PubMed ID: 20068338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.